Jan 16 (Reuters) - Guerbet SA GRBT.PA :
* 2023 STRATEGIC PRIORITIES
* 2023 STRATEGIC PRIORITIES: DIAGNOSTIC IMAGING: INCREASE
ELUCIREMTM SALES AND STRENGTHEN INTERNATIONAL POSITIONS
* 2023 STRATEGIC PRIORITIES: INTERVENTIONAL IMAGING:
PRIORITISE
LIPIODOL SALES WITH THE DEVELOPMENT OF INNOVATIVE INDICATIONS
* 2023 STRATEGIC PRIORITIES: ARTIFICIAL INTELLIGENCE:
EXECUTION OF
ROADMAP FOR EMERGENCE OF A MAJOR AI PLAYER DEDICATED TO MEDICAL
IMAGING IN ONCOLOGY
Source text for Eikon: ID:nGNX7pd02d
Further company coverage: GRBT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))